M&A Deal Summary

Aphria Acquires SOL Global Investments

On July 17, 2018, Aphria acquired business services company SOL Global Investments for 280M CAD

Acquisition Highlights
  • This is Aphria’s 1st transaction in the Business Services sector.
  • This is Aphria’s 2nd largest (disclosed) transaction.
  • This is Aphria’s 2nd transaction in Canada.
  • This is Aphria’s 2nd transaction in Ontario.

M&A Deal Summary
Date 2018-07-17
Target SOL Global Investments
Sector Business Services
Buyer(s) Aphria
Deal Type Add-on Acquisition
Deal Value 280M CAD

Target

SOL Global Investments

Toronto, Ontario, Canada
SOL Global Investments Corp. is an international investment company with a focus on cannabis and cannabis-related companies in legal U.S. states. SOL Global Investments is based in Toronto, Ontario.

Search 200,388 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Aphria

Leamington, Ontario, Canada
Category Company
Founded 2013
Sector Life Science
Employees1,200
Revenue 561M USD (2020)
DESCRIPTION

Aphria is an operator of a cannabis company with low-cost production of high-quality cannabis at scale, grown in the most natural conditions possible. Focusing on untapped opportunities and backed by the latest technologies, Aphria Inc. is committed to bringing breakthrough innovation to the global cannabis market. The Company’s portfolio of brands is grounded in expertly researched consumer insights designed to meet the needs of every consumer segment. Aphria was founded in 2013 and is based in Leamington, Ontario.

DEAL STATS #
Overall 2 of 4
Sector (Business Services) 1 of 1
Type (Add-on Acquisition) 2 of 4
State (Ontario) 2 of 2
Country (Canada) 2 of 2
Year (2018) 2 of 3
Size (of disclosed) 2 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-01-29 Nuuvera

Brampton, Ontario, Canada

Nuuvera, Inc., is a global cannabis company operates in Europe, Africa, and the Middle East.

Buy CA$826M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2018-11-08 CC Pharma

Densborn, Germany

CC Pharma GmbH is a distributor of pharmaceutical products to more than 13,000 pharmacies. CC Pharma is based in Densborn, Germany.

Buy €25M
Mergr

Product

Company

Legal